Page last updated: 2024-10-25

debrisoquin and Coma

debrisoquin has been researched along with Coma in 2 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerstenbrand, F1
Hackl, JM1
Rumpl, E1
Muldowney, FP1

Other Studies

2 other studies available for debrisoquin and Coma

ArticleYear
[Use of a beta blocker in a traumatic apallic syndrome].
    Psychiatrie, Neurologie, und medizinische Psychologie, 1981, Volume: 33, Issue:11

    Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Brain Injuries; Brain Stem; Coma; Debrisoquin; Dr

1981
Management of severe hypertension.
    Journal of the Irish Medical Association, 1972, Dec-09, Volume: 65, Issue:23

    Topics: Chlorthalidone; Coma; Debrisoquin; Diazoxide; Guanethidine; Humans; Hypertension, Malignant; Methyld

1972
chemdatabank.com